Hemocompatibility-related outcomes in the MOMENTUM 3 trial at 6 months: A randomized controlled study of a fully magnetically levitated pump in advanced heart failure

Circulation

Volumn 135, Issue 21, 2017, Pages 2003-2012

  Uriel, Nir ^a   Colombo, Paolo C ^b   Cleveland, Joseph C ^c   Long, James W ^d   Salerno, Christopher ^e   Goldstein, Daniel J ^f   Patel, Chetan B ^g   Ewald, Gregory A ^h   Tatooles, Antone J ⁱ   Silvestry, Scott C ^j   John, Ranjit ^k   Caldeira, Christiano ^l   Jeevanandam, Valluvan ^a   Boyle, Andrew J ^m   Sundareswaran, Kartik S ⁿ   Sood, Poornima ⁿ   Mehra, Mandeep R ^o  

^a UNIVERSITY OF CHICAGO   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^d INTEGRIS BAPTIST MEDICAL CENTER   (United States)

^e St Vincent Heart Center of Indiana   (United States)

^f MONTEFIORE MEDICAL CENTER   (United States)

^g DUKE UNIVERSITY   (United States)

^h WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ ADVOCATE CHRIST MEDICAL CENTER   (United States)

^j FLORIDA HOSPITAL   (United States)

^k UNIVERSITY OF MINNESOTA MEDICAL CENTER   (United States)

^l TAMPA GENERAL HOSPITAL   (United States)

^m THOMAS JEFFERSON UNIVERSITY   (United States)

ⁿ ABBOTT LABORATORIES   (United States)

^o BRIGHAM AND WOMEN S HOSPITAL   (United States)

more..

Author keywords

Biocompatible materials; Circulatory and respiratory physiological phenomena; Heart failure; Heart assist devices; Hemorrhage; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID;

ADULT; AGE; AGED; ARTICLE; BIOCOMPATIBILITY; BLEEDING; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; FEMALE; HEART FAILURE; HUMAN; INTERNATIONAL NORMALIZED RATIO; LEFT VENTRICULAR ASSIST DEVICE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REOPERATION; SECONDARY ANALYSIS; THROMBOSIS; ADVERSE EFFECTS; CLINICAL TRIAL; COMPARATIVE STUDY; DEVICE FAILURE; DEVICE REMOVAL; DISEASE FREE SURVIVAL; EQUIPMENT DESIGN; HEART ASSIST DEVICE; HEART LEFT VENTRICLE FUNCTION; HEMOLYSIS; KAPLAN MEIER METHOD; MAGNET; MATERIALS TESTING; MECHANICAL STRESS; MIDDLE AGED; ODDS RATIO; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK FACTOR; STROKE; TIME FACTOR; TREATMENT OUTCOME;

AGED; DEVICE REMOVAL; DISEASE-FREE SURVIVAL; EQUIPMENT DESIGN; EQUIPMENT FAILURE; FEMALE; HEART FAILURE; HEART-ASSIST DEVICES; HEMOLYSIS; HUMANS; KAPLAN-MEIER ESTIMATE; MAGNETS; MALE; MATERIALS TESTING; MIDDLE AGED; ODDS RATIO; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; STRESS, MECHANICAL; STROKE; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 85018462175     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.117.028303     Document Type: Article

References (20)

1. Mehra MR. The burden of haemocompatibility with left ventricular assist systems: A complex weave. Eur Heart J 2017. doi: Https:// doi.org/10.1093/eurheartj/ehx036.
2. Rogers JG, Pagani FD, Tatooles AJ, Bhat G, Slaughter MS, Birks EJ, Boyce SW, Najjar SS, Jeevanandam V, Anderson AS, Gregoric ID, Mallidi H, Leadley K, Aaronson KD, Frazier OH, Milano CA. Intrapericardial left ventricular assist device for advanced heart failure. N Engl J Med. 2017;376:451-460. doi: 10.1056/NEJMoa1602954.
3. Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, Sun B, Tatooles AJ, Delgado RM 3rd, Long JW, Wozniak TC, Ghumman W, Farrar DJ, Frazier OH; HeartMate II Investigators. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361:2241-2251. doi: 10.1056/NEJMoa0909938.
4. Netuka I, Sood P, Pya Y, Zimpfer D, Krabatsch T, Garbade J, Rao V, Morshuis M, Marasco S, Beyersdorf F, Damme L, Schmitto JD. Fully magnetically levitated left ventricular assist system for treating advanced HF: A multicenter study. J Am Coll Cardiol. 2015;66:2579-2589. doi: 10.1016/j.jacc.2015.09.083.
5. Heatley G, Sood P, Goldstein D, Uriel N, Cleveland J, Middlebrook D, Mehra MR; MOMENTUM 3 Investigators. Clinical trial design and rationale of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) investigational device exemption clinical study protocol. J Heart Lung Transplant. 2016;35:528-536. doi: 10.1016/j.healun.2016.01.021.
6. Mehra MR, Naka Y, Uriel N, Goldstein DJ, Cleveland JC Jr, Colombo PC, Walsh MN, Milano CA, Patel CB, Jorde UP, Pagani FD, Aaronson KD, Dean DA, McCants K, Itoh A, Ewald GA, Horstmanshof D, Long JW, Salerno C; MOMENTUM 3 Investigators. A fully magnetically levitated circulatory pump for advanced heart failure. N Engl J Med. 2017;376:440-450. doi: 10.1056/NEJMoa1610426.
7. Uriel N, Pak SW, Jorde UP, Jude B, Susen S, Vincentelli A, Ennezat PV, Cappleman S, Naka Y, Mancini D. Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation. J Am Coll Cardiol. 2010;56:1207-1213. doi: 10.1016/j.jacc.2010.05.016.
8. Boyle AJ, Jorde UP, Sun B, Park SJ, Milano CA, Frazier OH, Sundareswaran KS, Farrar DJ, Russell SD; HeartMate II Clinical Investigators. Pre-operative risk factors of bleeding and stroke during left ventricular assist device support: An analysis of more than 900 HeartMate II outpatients. J Am Coll Cardiol. 2014;63:880-888. doi: 10.1016/j.jacc.2013.08.1656.
9. Najjar SS, Slaughter MS, Pagani FD, Starling RC, McGee EC, Eckman P, Tatooles AJ, Moazami N, Kormos RL, Hathaway DR, Najarian KB, Bhat G, Aaronson KD, Boyce SW; HVAD Bridge to Transplant ADVANCE Trial Investigators. An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial. J Heart Lung Transplant. 2014;33:23-34. doi: 10.1016/j.healun.2013.12.001.
10. Frontera JA, Starling R, Cho SM, Nowacki AS, Uchino K, Hussain MS, Mountis M, Moazami N. Risk factors, mortality, and timing of ischemic and hemorrhagic stroke with left ventricular assist devices (published online ahead of print December 23, 2016). J Heart Lung Transplant. doi: 10.1016/j.healun.2016.12.010. https://www.ncbi. nlm.nih.gov/pubmed/?term=Frontera+JA%2C+Starling+R%2C+Ch o+SM%2C+Nowacki+AS%2C+Uchino+K%2C+Hussain+MS%2C+ Mountis+M%2C+Moazami+N. Accessed March 21, 2017.
11. Bourque K, Cotter C, Dague C, Harjes D, Dur O, Duhamel J, Spink K, Walsh K, Burke E. Design Rationale and preclinical evaluation of the HeartMate 3 left ventricular assist system for hemocompatibility. ASAIO J. 2016;62:375-383. doi: 10.1097/ MAT.0000000000000388.
12. Muthiah K, Connor D, Ly K, Gardiner EE, Andrews RK, Qiao J, Rutgers D, Robson D, Low J, Jarvis S, Macdonald P, Dhital K, Jansz P, Joseph J, Hayward CS. Longitudinal changes in hemostatic parameters and reduced pulsatility contribute to non-surgical bleeding in patients with centrifugal continuous-flow left ventricular assist devices. J Heart Lung Transplant. 2016;35:743-751. doi: 10.1016/j.healun.2015.12.024.
13. Netuka I, Kvasnicka T, Kvasnicka J, Hrachovinová I, Ivák P, Marecek F, Bílková J, Malíková I, Jancová M, Maly J, Sood P, Sundareswaran KS, Connors JM, Mehra MR. Evaluation of von Willebrand factor with a fully magnetically levitated centrifugal continuous- flow left ventricular assist device in advanced heart failure. J Heart Lung Transplant. 2016;35:860-867. doi: 10.1016/j. healun.2016.05.019.
14. Stewart GC, Givertz MM, Mehra MR. Pump thrombosis redux. J Heart Lung Transplant. 2015;34:1511-1514. doi: 10.1016/j. healun.2015.10.038.
15. Kirklin JK, Naftel DC, Pagani FD, Kormos RL, Myers S, Acker MA, Rogers J, Slaughter MS, Stevenson LW. Pump thrombosis in the Thoratec HeartMate II device: An update analysis of the INTERMACS Registry. J Heart Lung Transplant. 2015;34:1515-1526. doi: 10.1016/j.healun.2015.10.024.
16. Stulak JM, Dunlay SM, Sharma S, Haglund NA, Davis MB, Cowger J, Shah P, Masood F, Aaronson KD, Pagani FD, Maltais S. Treatment of device thrombus in the HeartWare HVAD: Success and outcomes depend significantly on the initial treatment strategy. J Heart Lung Transplant. 2015;34:1535-1541. doi: 10.1016/j. healun.2015.10.020.
17. Smedira NG, Blackstone EH, Ehrlinger J, Thuita L, Pierce CD, Moazami N, Starling RC. Current risks of HeartMate II pump thrombosis: Non-parametric analysis of Interagency Registry for Mechanically Assisted Circulatory Support data. J Heart Lung Transplant. 2015;34:1527-1534. doi: 10.1016/j.healun.2015.10.027.
18. Netuka I, Litzler PY, Berchtold-Herz M, Flecher E, Zimpfer D, Damme L, Sundareswaran KS, Farrar DJ, Schmitto JD; EU TRACE Investigators. Outcomes in HeartMate II patients with no antiplatelet therapy: 2-year results from the European TRACE Study (published online ahead of print October 12, 2016). Ann Thorac Surg. doi: 10.1016/j.athoracsur.2016.07.072. https://www. ncbi.nlm.nih.gov/pubmed/?term=Netuka+I%2C+Litzler+PY%2C+ Berchtold-Herz+M%2C+Flecher+E%2C+Zimpfer+D%2C+Damme +L%2C+Sundareswaran+KS%2C+Farrar+DJ%2C+Schmitto+JD. Accessed March 21, 2017.
19. Teuteberg JJ, Slaughter MS, Rogers JG, McGee EC, Pagani FD, Gordon R, Rame E, Acker M, Kormos RL, Salerno C, Schleeter TP, Goldstein DJ, Shin J, Starling RC, Wozniak T, Malik AS, Silvestry S, Ewald GA, Jorde UP, Naka Y, Birks E, Najarian KB, Hathaway DR, Aaronson KD; ADVANCE Trial Investigators. The HVAD left ventricular assist device: Risk factors for neurological events and risk mitigation strategies. JACC Heart Fail. 2015;3:818-828. doi: 10.1016/j.jchf.2015.05.011.
20. Uriel N, Han J, Morrison KA, Nahumi N, Yuzefpolskaya M, Garan AR, Duong J, Colombo PC, Takayama H, Thomas S, Naka Y, Jorde UP. Device thrombosis in HeartMate II continuous-flow left ventricular assist devices: A multifactorial phenomenon. J Heart Lung Transplant. 2014;33:51-59. doi: 10.1016/j.healun.2013.10.005.